Elizabeth C Goode MD

Dr Goode graduated from Imperial College London in 2009, with Bachelor of Medicine, Bachelor of Surgery and 1^st class intercalated Bachelor of Science degree in Medical Sciences with Haematology. Her undergraduate research, under the supervision of Professor Mike Laffan at the MRC London Institute of Medical Sciences, focused on deciphering the function of N-linked glycans on the synthesis and function of von Willebrand Factor. In 2011, she commenced an NIHR Academic Clinical Fellowship in Gastroenterology, gaining her Membership of the Royal College of Physicians shortly afterwards. She quickly developed an interest in immune-mediated liver diseases, specifically primary sclerosing cholangitis (PSC). Alongside her clinical training in Gastroenterology and Hepatology, she spent several years working with the UK-PSC Consortium, under the supervision of Dr Simon Rushbrook and Dr Gideon Hirschfield, where she developed and published the UK-PSC risk score; a clinical risk score that predicts adverse outcome in patients with PSC (http://www.uk-psc.com/resources/the-uk-psc-risk-scores/).

In 2016 Dr Goode was awarded a University of Cambridge Wellcome Trust Clinical PhD Fellowship and joined the Wellcome Trust Sanger Institute in Cambridge, under the supervision of Dr Carl Anderson. Here, her work has focused on furthering our understanding of genetic variants associated with PSC risk, using a combination of computational statistical and wet-lab approaches in the generation and analysis of RNA sequencing data.  Alongside this, she holds her Royal College of Physicians Specialty Certificate in Gastroenterology and continues to work as a Senior Clinical Fellow in Transplant Hepatology at Addenbrookes Hospital in Cambridge, UK.